» Authors » Clare French

Clare French

Explore the profile of Clare French including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 625
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoskins S, Beale S, Nguyen V, Fragaszy E, Navaratnam A, Smith C, et al.
Wellcome Open Res . 2023 Mar; 7:199. PMID: 36874571
: "Lockdowns" to control serious respiratory virus pandemics were widely used during the coronavirus disease 2019 (COVID-19) pandemic.  However, there is limited information to understand the settings in which most...
2.
Grebely J, Tran L, Degenhardt L, Dowell-Day A, Santo T, Larney S, et al.
Clin Infect Dis . 2020 May; 73(1):e107-e118. PMID: 32447375
Background: People who inject drugs (PWID) experience barriers to accessing testing and treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an opportunity to improve access...
3.
Caldwell D, Davies S, Hetrick S, Palmer J, Caro P, Lopez-Lopez J, et al.
Lancet Psychiatry . 2019 Nov; 6(12):1011-1020. PMID: 31734106
Background: Rates of anxiety and depression are increasing among children and young people. Recent policies have focused on primary prevention of mental disorders in children and young people, with schools...
4.
Borsotti C, Danzl N, Nauman G, Holzl M, French C, Chavez E, et al.
Blood Adv . 2018 Jan; 1(23):2007-2018. PMID: 29296847
B cells play a major role in antigen presentation and antibody production in the development of autoimmune diseases, and some of these diseases disproportionally occur in females. Moreover, immune responses...
5.
Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al.
Cochrane Database Syst Rev . 2017 Sep; 9:CD012021. PMID: 28922449
Background: Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugsNeedle syringe programmes (NSP) and opioid substitution therapy (OST) are the primary interventions...
6.
Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al.
Addiction . 2017 Sep; 113(3):545-563. PMID: 28891267
Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people...
7.
Low A, Mburu G, Welton N, May M, Davies C, French C, et al.
Clin Infect Dis . 2016 Jun; 63(8):1094-1104. PMID: 27343545
Background: Human immunodeficiency virus (HIV)-infected people who inject drugs (PWID) frequently encounter barriers accessing and remaining on antiretroviral therapy (ART). Some studies have suggested that opioid substitution therapy (OST) could...
8.
Platt L, Reed J, Minozzi S, Vickerman P, Hagan H, French C, et al.
Cochrane Database Syst Rev . 2016 Apr; 2016(1). PMID: 27127417
Research Questions: How effective are needle/syringe programmes (NSP) with and without the use of OST for reducing HCV incidence among PWID?How effective is OST alone for reducing HCV incidence among...
9.
Weiss A, Hollandsworth H, Alseidi A, Scovel L, French C, Derrick E, et al.
Curr Probl Surg . 2016 Apr; 53(4):165-205. PMID: 27102336
No abstract available.
10.
Tariq S, Elford J, Chau C, French C, Cortina-Borja M, Brown A, et al.
Sex Transm Dis . 2016 Apr; 43(5):283-9. PMID: 27100763
Background: Little is known about retention in human immunodeficiency virus (HIV) care in HIV-positive women after pregnancy in the United Kingdom. We explored the association between loss to follow-up (LTFU)...